Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept.

Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, Thiesen HJ.

Arthritis Res Ther. 2008;10(3):R50. Epub 2008 May 2.

PMID: 18454843 [PubMed - in process]

Related Articles Free article in PMC

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG.

Pharmacogenomics. 2004 Oct;5(7):952-1004.

PMID: 15469413 [PubMed - indexed for MEDLINE]

Related Articles

Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.

Toh ML, Marotte H, Blond JL, Jhumka U, Eljaafari A, Mougin B, Miossec P.

Arthritis Rheum. 2006 Jul;54(7):2109-18.

PMID: 16802346 [PubMed - indexed for MEDLINE]

Related Articles

Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.

Park MC, Jung SJ, Park YB, Lee SK.

Scand J Rheumatol. 2008 May-Jun;37(3):173-8.

PMID: 18465450 [PubMed - indexed for MEDLINE]

Related Articles

The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.

Seitz M, Wirthmüller U, Möller B, Villiger PM.

Rheumatology (Oxford). 2007 Jan;46(1):93-6. Epub 2006 May 23.

PMID: 16720636 [PubMed - indexed for MEDLINE]

Related Articles

Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients.

Lindberg J, af Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, Lundeberg J.

Arthritis Res Ther. 2006;8(6):R179.

PMID: 17134501 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis.

Lequerré T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, Vittecoq O, Daveau M, Mejjad O, Daragon A, Tron F, Le Loët X, Salier JP.

Arthritis Res Ther. 2006;8(4):R105.

PMID: 16817978 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model.

Shou J, Bull CM, Li L, Qian HR, Wei T, Luo S, Perkins D, Solenberg PJ, Tan SL, Chen XY, Roehm NW, Wolos JA, Onyia JE.

Arthritis Res Ther. 2006;8(1):R28. Epub 2006 Jan 10.

PMID: 16507131 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.

Berg L, Rönnelid J, Sanjeevi CB, Lampa J, Klareskog L.

Arthritis Res. 2000;2(1):75-84.

PMID: 11219392 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Bobbio-Pallavicini F, Caporali R, Alpini C, Avalle S, Epis OM, Klersy C, Montecucco C.

Ann Rheum Dis. 2007 Mar;66(3):302-7. Epub 2006 Nov 1.

PMID: 17079248 [PubMed - indexed for MEDLINE]

Related Articles

Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.

van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP.

Ann Rheum Dis. 2008 Apr;67(4):563-6. Epub 2007 Nov 27.

PMID: 18042642 [PubMed - indexed for MEDLINE]

Related Articles

Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.

Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.

Arthritis Rheum. 2007 Jul;56(7):2160-9.

PMID: 17599736 [PubMed - indexed for MEDLINE]

Related Articles

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.

PMID: 16673249 [PubMed - indexed for MEDLINE]

Related Articles

Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.

Schuerwegh AJ, Van Offel JF, Stevens WJ, Bridts CH, De Clerck LS.

Rheumatology (Oxford). 2003 Apr;42(4):541-8.

PMID: 12649401 [PubMed - indexed for MEDLINE]

Related Articles

Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study.

Giacomelli R, Cipriani P, Matucci Cerinic M, Fulminis A, Barattelli G, Pingiotti E, Di Franco M, Trotta A, Perricone R, Zazzeroni F, Alesse E, Tonietti G.

Clin Exp Rheumatol. 2002 May-Jun;20(3):365-72.

PMID: 12102473 [PubMed - indexed for MEDLINE]

Related Articles

Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.

Vázquez I, Graell E, Gratacós J, Cañete JD, Viñas O, Ercilla MG, Gómez A, Hernández MV, Rodríguez-Cros JR, Larrosa M, Sanmartí R.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):231-8.

PMID: 17543147 [PubMed - indexed for MEDLINE]

Related Articles

Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.

Parker A, Izmailova ES, Narang J, Badola S, Le T, Roubenoff R, Ginsburg GS, Maier A, Coblyn JS, Shadick NA, Weinblatt ME.

J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.

PMID: 17696278 [PubMed - indexed for MEDLINE]

Related Articles

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A.

BMC Musculoskelet Disord. 2008 Apr 17;9:52. Review.

PMID: 18419803 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB.

Ann Rheum Dis. 2001 Jul;60(7):660-9.

PMID: 11406520 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.

Benucci M, Saviola G, Baiardi P, Cammelli E, Manfredi M.

Clin Rheumatol. 2008 Jan;27(1):91-5. Epub 2007 Oct 10.

PMID: 17929076 [PubMed - indexed for MEDLINE]

Related Articles